Renaissance Capital logo

BUDA News

US IPO Weekly Recap: Aktis Oncology leads as first sizable 2026 IPO

AKTS

Three IPOs and five SPACs priced this week. Six IPOs and two SPACs submitted initial filings. In the first sizable deal of 2026, solid tumor biotech Aktis Oncology (AKTS) priced its upsized IPO at the high end of the range to raise $318 million at a $1.0...read more

Texas-based juice brand Buda Juice raises $20 million pricing IPO at $7.50, the low end of the range

Buda Juice logo

Buda Juice, which makes branded and private label citrus drinks, raised $20 million by offering 2.7 million shares at $7.50, the low end of the range of $7.50 to $9.00.  Buda Juice states that it is pioneering the "UltraFresh" juice category through its...read more

Juice manufacturer Buda Juice sets terms for $22 million IPO

Buda Juice logo

Buda Juice, which makes branded and private label citrus drinks, announced terms for its IPO on Monday. The Dallas, TX-based company plans to raise $22 million by offering 2.7 million shares (25% secondary) at a price range of $7.50 to $9.00. At the midpoint...read more

Juice manufacturer Buda Juice files for a $22 million IPO

Buda Juice logo

Buda Juice, which makes branded and private label citrus drinks, filed on Wednesday with the SEC to raise up to $22 million in an initial public offering. Buda Juice states that it is pioneering the "UltraFresh" juice category through its end-to-end cold...read more

Archived Headlines